Blue Cross Blue Shield · SUD Residential · US health-plan appeal rights

SUD Residential denied for failing step therapy by Blue Cross Blue Shield?

Q: How long do I have to appeal a Blue Cross Blue Shield SUD Residential denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-10

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What Blue Cross Blue Shield typically requires

Blue Cross Blue Shield's specific coverage criteria for sud residential are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: Anthem clinical guideline (SUD Treatment) + BCBS plan-specific MAT policies

The Blue Cross Blue Shield angle on SUD Residential

## Why BCBS Denied Residential SUD Treatment — Step Therapy

A step-therapy denial on residential substance use disorder (SUD) treatment means BCBS is asserting that the patient must first try — and fail — a less intensive level of care before residential treatment will be covered. In the behavioral health context, this approach is clinically and legally problematic. Step therapy was designed for medication management, not for level-of-care determinations in acute SUD care, where delayed or insufficient treatment can result in severe harm.

## Why This Denial Is Appealable

Applying step-therapy logic to residential SUD placement conflicts with established clinical criteria (such as ASAM's multidimensional assessment model), which base the appropriate level of care on the patient's current clinical presentation — not on a formulaic sequence of failed lower-level attempts. The Mental Health Parity and Addiction Equity Act (MHPAEA) also bars the use of treatment limitation standards for SUD benefits that are more restrictive than those applied to analogous medical or surgical care. Requiring a patient to fail outpatient treatment before accessing residential care, when no equivalent "fail first" requirement exists for medical inpatient admission, is a classic parity violation. Many states have also enacted step-therapy exception laws that apply to behavioral health.

## Federal Appeal Framework

Internal appeal (Level 1): File within the plan-stated deadline. Request the specific step-therapy protocol in writing and the clinical criteria used to determine that the patient has not yet satisfied the step requirement.
Step-therapy exception request: In parallel with the appeal, formally request a step-therapy exception. Document why the lower level of care was already tried and failed, is contraindicated, or would cause clinical harm.
External review (ACA §2719): After a final internal denial, request independent external review within approximately four months. An IRO will assess clinical appropriateness and may also consider parity compliance.
ERISA §503: Self-funded plan members have full-and-fair review rights and may challenge the step-therapy protocol itself as a plan term.
Expedited review: For current or imminent admissions, request expedited review (72-hour turnaround).

## Documentation to Gather

Records of prior outpatient or intensive outpatient SUD treatment attempts, with dates, duration, outcomes, and reasons for failure or step-up
Clinical documentation showing why a lower level of care is currently inadequate or unsafe (ASAM assessment addressing all six dimensions)
Treating clinician's letter explaining the clinical rationale for residential level and why step-therapy sequencing is inappropriate for this patient
Any documentation of medical contraindications to lower-level care (e.g., co-occurring medical or psychiatric conditions)
BCBS's published step-therapy policy and the plan benefit document

## Criteria-Mapping Structure

Obtain the exact step-therapy requirements from BCBS's published policy. For each step listed, document either (a) that the step was already completed (with dates and outcomes) or (b) that the step is clinically inappropriate for this patient, with chart-based evidence. Present the parity argument as a separate section: identify the analogous medical/surgical benefit, confirm no equivalent step requirement exists, and cite MHPAEA. A strong appeal combines both a clinical necessity argument and a structural parity challenge.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other Blue Cross Blue Shield appeals

Other denial reasons for Blue Cross Blue Shield SUD Residential

denied as not medically necessary denied as non-formulary denied for missing prior authorization denied as experimental or investigational denied as not FDA-approved for this use

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-10. Editorial standards: denialhelp.com/authors.